A phase I trial of MK-0731, a Kinesin Sp
A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors
✍
Kyle Holen, Robert DiPaola, Glenn Liu, Antoinette R. Tan, George Wilding, Karl H
📂
Article
📅
2011
🏛
Springer US
🌐
English
⚖ 242 KB